References
- Cao Y, Jin Y, Yu J, Wang J, Qiu Y, Duan X, et al. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification. Oncotarget. 2017;8:49689–701.
- van Wezel EM, Stutterheim J, Vree F, Zappeij-Kannegieter L, Decarolis B, Hero B, et al. Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. Pediatr Blood Cancer. 2015;62:1368–73.
- Gupta H, Conrad J, Khoury JD, McGregor LM, Krasin MJ, Dome JS, et al. Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer. 2007;49:906–8.
- Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, et al. Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute Clinical Trials planning meeting. J Clin Oncol. 2017;35(22):2580–7.
- Ferreira-Facio CS, Milito C, Botafogo V, Fontana M, Thiago LS, Oliveira E, et al. Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer. PLoS One. 2013;8:e55534.
- Swerts K, De Moerloose B, Dhooge C, Brichard B, Benoit Y, Laureys G, et al. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry. Cytometry B Clin Cytom. 2004;61:9–19.
- Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298–303.
- Cesana C, Klersy C, Scarpati B, Brando B, Faleri M, Bertani G, et al. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome. Ann Hematol. 2011;90:827–35.
- Pillai V, Dorfman DM. Flow cytometry of nonhematopoietic neoplasms. Acta Cytol. 2016;60:336–43.
- Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time? Cancer. 2012;118:1747–53.
- Shen H, Tang Y, Xu X, Wang L, Wang Q, Xu W, et al. Rapid detection of neoplastic cells in serous cavity effusions in children with flow cytometry immunophenotyping. Leuk Lymphoma. 2012;53:1509–14.
- Kentrou NA, Tsagarakis NJ, Tzanetou K, Damala M, Papadimitriou KA, Skoumi D, et al. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Cytometry B Clin Cytom. 2011;80:324–34.
- Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014;122:657–65.
- Cowie F, Corbett R, Pinkerton CR. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol. 1997;28:429–32.